Grand Pharmaceutical Group Limited - 0512.HK

0512.HK Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
0512.HK	-1.1	-4.0	-8.0	-7.8	-2.0	28.2	-32.0	-17.3	1460.5	1814.5
S&P 500	1.0	1.5	1.1	2.3	8.9	23.6	33.8	80.6	196.5	33856.2

Compare 0512.HK with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	0512.HK
name	Grand Pharmaceutical Group Limited
price	4.36
changes percentage	-1.13
change	-0.05
day low	4.36
day high	4.48
year high	5.62
year low	3.17
market cap	15267885060
price avg 50	4.62
price avg 200	4.59
exchange	HKSE
volume	3655500
avg volume	2633222
open	4.42
previous close	4.41
eps	0.69
pe	6.32
earnings announcement	2025-03-27T12:00:00.000+0000
shares outstanding	3501808500
timestamp	2025-01-20 08:08:32

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 56.7%

Overall Quarterly Financial Health: 43.7%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	10529590000	9562285000	10.12
gross profit	6524066000	5951479000	9.62
gross profit ratio	0.62	0.62	-0.45
research and development expenses	571985000	531924000	7.53
operating expenses	3860669000	3433855000	12.43
interest income	7745000	19806000	-60.90
interest expense	205145000	137493000	49.20
ebitda	2966560000	3093084000	-4.09
ebitdaratio	0.28	0.3	-7.50
operating income	2663397000	2517624000	5.79
operating income ratio	0.25	0.26	-3.93
net income	1879998000	2079419000	-9.59
net income ratio	0.18	0.22	-17.90
eps	0.54	0.59	-8.47

Overall Score of Annual Income Statement

0.38 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 10,530 million in 2023 from 9,562 million in 2022 representing a change of 10.12%. This indicates a sales shrinking, which is a negative sign for the company.

  Operating Expenses: Operating Expenses increased to 3,861 million in 2023 from 3,434 million in 2022 representing a change of 12.43%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 2,967 million in 2023 from 3,093 million in 2022 representing a change of -4.09%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Net Income: Net income decreased to 1,880 million in 2023 from 2,079 million in 2022 representing a change of -9.59%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 0.54 in 2023 from 0.54 in 2022 representing a change of -8.47%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• 📈 Positive Indicators

  Gross Profit: Gross Profit increased to 6,524 million in 2023 from 5,951 million in 2022 representing a change of 9.62%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 572 million in 2023 from 532 million in 2022 representing a change of 7.53%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  Operating Income: Operating income increased to 2,663 million in 2023 from 2,518 million in 2022 representing a change of 5.79%. The increase in operating income indicates better operational performance and increased profitability.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2023Q4	Q/Q change %
0000000000
revenue	6047236000	4540104000	33.20
gross profit	3591309000	2655629000	35.23
gross profit ratio	0.59	0.58	1.53
research and development expenses	300677000	216009000	39.20
operating expenses	2218152000	1527104000	45.25
interest income	0	0	NaN
interest expense	86121000	91912000	-6.30
ebitda	2148346000	1329264000	61.62
ebitdaratio	0.36	0.29	21.35
operating income	1373157000	1128525000	21.68
operating income ratio	0.23	0.25	-8.65
net income	1557945000	850644000	83.15
net income ratio	0.26	0.19	37.50
eps	0.44	0.24	83.33

Overall Score of Quarterly Income Statement

0.75 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 6,047 million in 2024Q2 from 4,540 million in 2023Q4 representing a change of 33.2%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 3,591 million in 2024Q2 from 2,656 million in 2023Q4 representing a change of 35.23%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 301 million in 2024Q2 from 216 million in 2023Q4 representing a change of 39.2%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 2,148 million in 2024Q2 from 1,329 million in 2023Q4 representing a change of 61.62%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 1,373 million in 2024Q2 from 1,129 million in 2023Q4 representing a change of 21.68%. The increase in operating income indicates better operational performance and increased profitability.

  Earnings per Share (EPS): EPS increased to 0.44 in 2024Q2 from 0.44 in 2023Q4 representing a change of 83.33%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 2,218 million in 2024Q2 from 1,527 million in 2023Q4 representing a change of 45.25%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  Net Income: Net income decreased to 1,558 million in 2024Q2 from 851 million in 2023Q4 representing a change of 83.15%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	22515326000	22371061000	0.64
total liabilities	7244810000	8162401000	-11.24
total equity	15270516000	14208660000	7.47
cash and cash equivalents	1339708000	1445371000	-7.31
short term investments	1134590000	1038582000	9.24
long term investments	8221920000	8446593000	-2.66
total current assets	7016145000	6886920000	1.88
total non current assets	15499181000	15484141000	0.10
total current liabilities	5731437000	6454601000	-11.20
total non current liabilities	1513373000	1707800000	-11.38
common stock	35496000	35496000	0.00
retained earnings	8868228000	7543775000	17.56
total debt	3404239000	4475282000	-23.93

Overall Score of Annual Balance Sheet

0.89 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 22,515 million in 2023 from 22,371 million in 2022 representing a change of 0.64%. Suggesting a growth in asset holdings.

  Total Liabilities: Total Liabilities decreased to 7,245 million in 2023 from 8,162 million in 2022 representing a change of -11.24%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 15,271 million in 2023 from 14,209 million in 2022 representing a change of 7.47%. This indicates an increase in shareholders' equity.

  Short Term Investments: Short Term Investments increased to 1,135 million in 2023 from 1,039 million in 2022 representing a change of 9.24%. This indicates an increase in short-term investment holdings.

  Total Current Assets: Total Current Assets increased to 7,016 million in 2023 from 6,887 million in 2022 representing a change of 1.88%. This indicates a better liquidity position.

  Total Current Liabilities: Total Current Liabilities decreased to 5,731 million in 2023 from 6,455 million in 2022 representing a change of -11.2%. This indicates a lower short-term debt burden.

  Retained Earnings: Retained Earnings increased to 8,868 million in 2023 from 7,544 million in 2022 representing a change of 17.56%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 3,404 million in 2023 from 4,475 million in 2022 representing a change of -23.93%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 1,340 million in 2023 from 1,445 million in 2022 representing a change of -7.31%. This indicates a decrease in available liquid assets.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q2	2023Q4	Q/Q change %
0000000000
total assets	24902042000	22515326000	10.60
total liabilities	9004055000	7244810000	24.28
total equity	15897987000	15270516000	4.11
cash and cash equivalents	763784000	1372380000	-44.35
short term investments	1587596000	1134590000	39.93
long term investments	8435425999	8397736999	0.45
total current assets	8241940000	7016145000	17.47
total non current assets	16660101999	15499181000	7.49
total current liabilities	6399428000	5731437000	11.65
total non current liabilities	2604627000	1513373000	72.11
common stock	35496000	35496000	0.00
retained earnings	9500861000	8868228000	7.13
total debt	4541893000	3404239000	33.42

Overall Score of Quarterly Balance Sheet

0.56 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 24,902 million in 2024Q2 from 22,515 million in 2023Q4 representing a change of 10.6%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 15,898 million in 2024Q2 from 15,271 million in 2023Q4 representing a change of 4.11%. This indicates an increase in shareholders' equity.

  Short Term Investments: Short Term Investments increased to 1,588 million in 2024Q2 from 1,135 million in 2023Q4 representing a change of 39.93%. This indicates an increase in short-term investment holdings.

  Total Current Assets: Total Current Assets increased to 8,242 million in 2024Q2 from 7,016 million in 2023Q4 representing a change of 17.47%. This indicates a better liquidity position.

  Retained Earnings: Retained Earnings increased to 9,501 million in 2024Q2 from 8,868 million in 2023Q4 representing a change of 7.13%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 9,004 million in 2024Q2 from 7,245 million in 2023Q4 representing a change of 24.28%. This indicates an increase in overall liabilities.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 764 million in 2024Q2 from 1,372 million in 2023Q4 representing a change of -44.35%. This indicates a decrease in available liquid assets.

  Total Current Liabilities: Total Current Liabilities increased to 6,399 million in 2024Q2 from 5,731 million in 2023Q4 representing a change of 11.65%. This indicates a higher short-term debt burden.

  Total Debt: Total Debt increased to 4,542 million in 2024Q2 from 3,404 million in 2023Q4 representing a change of 33.42%. This indicates an increase in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	-104306000	-315134000	66.90
operating cash flow	2424895000	1917084000	26.49
free cash flow	1927206000	245787000	684.10
capital expenditure	-497689000	-1671297000	70.22
depreciation and amortization	392210000	394912000	-0.68
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts payables	290649000	-234575000	223.90
inventory	-99408000	-295283000	66.33
acquisitions net	-169815000	-267236000	36.46
investments in property plant and equipment	-487727000	-1671297000	70.82
net cash used for investing activites	-515747000	-2577871000	79.99
debt repayment	-1054539000	917347000	-214.96
common stock issued	0	0	NaN
common stock repurchased	-81014000	-43986000	-84.18
dividends paid	-496940000	-390450000	-27.27
net cash used provided by financing activities	-1889399000	464493000	-506.77
cash at end of period	1339708000	1445371000	-7.31
accounts receivables	-198241000	-536765000	63.07
cash at beginning of period	1444014000	1760505000	-17.98

Overall Score of Annual Cashflow Statement

0.43 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to -104 million in 2023 from -315 million in 2022 representing a change of 66.9%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 2,425 million in 2023 from 1,917 million in 2022 representing a change of 26.49%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 1,927 million in 2023 from 246 million in 2022 representing a change of 684.1%. This indicates an increase in cash generated after accounting for capital expenditures.

• 📉 Negative Indicators

  Capital Expenditure: Capital Expenditure increased to -498 million in 2023 from -1,671 million in 2022 representing a change of 70.22%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Accounts Payables: The absolute value of Accounts Payables increased to 291 million in 2023 from 235 million in 2022 representing a change of 223.9%. This indicates that the company has increased its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables increased to -198 in 2023 from -537 million in 2022 representing a change of 63.07%. This suggests that the company is less capable of collecting payments from its customers.

  Dividends Paid: Dividends Paid decreased to -497 million in 2023 from -390 million in 2022 representing a change of -27.27%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2023Q4	Q/Q change %
0000000000
operating cash flow	140848000	1675753000	-91.59
free cash flow	-51563000	1415802000	-103.64
capital expenditure	-192411000	-259951000	25.98
depreciation and amortization	249159000	200655000	24.17
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts receivables	0	-177524000	100.00
accounts payables	0	0	NaN
inventory	0	-99408000	100.00
acquisitions net	-720292000	-29563000	-2,336.46
investments in property plant and equipment	-192617000	-259951000	25.90
net cash used for investing activites	-871416000	59790000	-1,557.46
debt repayment	0	-1109636000	100.00
common stock issued	0	0	NaN
common stock repurchased	0	-1965000	100.00
dividends paid	-922888000	0	NaN
net cash used provided by financing activities	270134000	-1228762000	121.98
net change in cash	-608596000	678768000	-189.66
cash at end of period	763784000	1372380000	-44.35
cash at beginning of period	1372380000	693612000	97.86

Overall Score of Quarterly Cashflow Statement

0.0 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to -609 million in 2024Q2 from 679 million in 2023Q4 representing a change of -189.66%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow decreased to 141 million in 2024Q2 from 1,676 million in 2023Q4 representing a change of -91.59%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to -52 million in 2024Q2 from 1,416 million in 2023Q4 representing a change of -103.64%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure increased to -192 million in 2024Q2 from -260 million in 2023Q4 representing a change of 25.98%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Accounts Receivables: Accounts Receivables increased to 0 in 2024Q2 from -178 million in 2023Q4 representing a change of 100.0%. This suggests that the company is less capable of collecting payments from its customers.

  Dividends Paid: Dividends Paid decreased to -923 million in 2024Q2 from 0 million in 2023Q4 representing a change of nan%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	3.0	2.7	11.20
net income per share	0.54	0.59	-8.70
operating cash flow per share	0.69	0.54	27.73
free cash flow per share	0.55	0.07	691.81
cash per share	0.71	0.7	0.59
book value per share	4.35	4.01	8.53
tangible book value per share	3.71	3.25	14.15
shareholders equity per share	4.32	3.99	8.25
interest debt per share	1.03	1.3	-20.98
market cap	14031016000	16294386800.0	-13.89
enterprise value	16095547000	19324297800	-16.71
pe ratio	7.46	7.84	-4.76
price to sales ratio	1.33	1.7	-21.80
pocfratio	5.79	8.5	-31.92
pfcf ratio	7.28	66.29	-89.02
pb ratio	0.93	1.15	-19.67
ptb ratio	0.93	1.15	-19.67
ev to sales	1.53	2.02	-24.36
enterprise value over ebitda	5.43	6.25	-13.16
ev to operating cash flow	6.64	10.08	-34.15
ev to free cash flow	8.35	78.62	-89.38
earnings yield	0.13	0.13	4.99
free cash flow yield	0.14	0.02	810.58
debt to equity	0.22	0.32	-29.04
debt to assets	0.15	0.2	-24.42
net debt to ebitda	0.7	0.98	-28.96
current ratio	1.22	1.07	14.73
interest coverage	12.98	18.31	-29.10
income quality	1.29	0.92	39.91
dividend yield	0.04	0.02	47.80
payout ratio	0.26	0.19	40.77
sales general and administrative to revenue	0.12	0.09	28.84
research and ddevelopement to revenue	0.05	0.06	-2.35
intangibles to total assets	0.1	0.12	-16.94
capex to operating cash flow	0.21	0.87	-76.46
capex to revenue	0.05	0.17	-72.96
capex to depreciation	1.27	4.23	-70.02
stock based compensation to revenue	0	0	NaN
graham number	7.22	7.26	-0.59
roic	0.11	0.11	2.43
return on tangible assets	0.09	0.11	-12.20
graham net net	-1.16	-0.95	-22.76
working capital	1284708000	432319000	197.17
tangible asset value	13025015000	11522574000	13.04
net current asset value	-228665000	-1275481000	82.07
invested capital	7515862000	7060307000	6.45
average receivables	1103458000	2178176000	-49.34
average payables	1101635500	803679000	37.07
average inventory	1364557500	1228811000	11.05
days sales outstanding	0	84.24	-100.00
days payables outstanding	121.23	88.23	37.40
days of inventory on hand	126.54	135.5	-6.61
receivables turnover	0	4.33	-100.00
payables turnover	3.01	4.14	-27.22
inventory turnover	2.88	2.69	7.08
roe	0.12	0.15	-15.66
capex per share	0.14	0.47	-69.93

• ROE:

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 7.46 on 2023-12-31 from 7.84 on 2022-12-31, representing a change of -4.76%. Indicating a decrease in the relative valuation of the company's stock.

• Positive

  Current Ratio: Current Ratio increased to 1.22 on 2023-12-31 from 1.07 on 2022-12-31, representing a change of 14.73%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.22 on 2023-12-31 from 0.32 on 2022-12-31, representing a change of -29.04%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-06-30 Q2	2023-12-31 Q4	Q/Q change %
0512.HK
calendar year	2024	2023	NaN
revenue per share	1.72	1.3	32.97
net income per share	0.44	0.24	82.84
operating cash flow per share	0.04	0.48	-91.61
free cash flow per share	-0.01	0.4	-103.64
cash per share	0.67	0.72	-6.37
book value per share	4.53	4.36	3.93
tangible book value per share	4.22	3.62	16.59
shareholders equity per share	4.48	4.33	3.52
interest debt per share	1.32	1.0	32.15
market cap	16311056100.0	14007238000	16.45
enterprise value	20089165100	16039097000	25.25
pe ratio	2.62	4.12	-36.42
price to sales ratio	2.7	3.09	-12.57
pocfratio	115.81	8.36	1,285.44
pfcf ratio	-316.33	9.89	-3,297.38
pb ratio	1.04	0.92	12.29
ptb ratio	1.04	0.92	12.29
ev to sales	3.32	3.53	-5.96
enterprise value over ebitda	9.35	12.07	-22.50
ev to operating cash flow	142.63	9.57	1,390.19
ev to free cash flow	-389.6	11.33	-3,539.11
earnings yield	0.1	0.06	57.28
free cash flow yield	-0.0	0.1	-103.13
debt to equity	0.29	0.22	28.66
debt to assets	0.18	0.15	20.63
net debt to ebitda	1.76	1.53	15.05
current ratio	1.29	1.22	5.21
interest coverage	15.94	12.28	29.86
income quality	0.09	1.97	-95.41
dividend yield	0.06	0	NaN
payout ratio	0.59	0	NaN
sales general and administrative to revenue	0	0.12	-100.00
research and ddevelopement to revenue	0.05	0.05	4.51
intangibles to total assets	0.04	0.12	-61.46
capex to operating cash flow	1.37	0.16	780.64
capex to revenue	0.03	0.06	-44.43
capex to depreciation	0.77	1.3	-40.39
stock based compensation to revenue	0	0	NaN
graham number	6.69	4.86	37.58
roic	0.06	0.05	16.23
return on tangible assets	0.07	0.04	53.25
graham net net	-0.73	-0.66	-11.01
working capital	1842512000	1284708000	43.42
tangible asset value	14785359000	12660376000	16.78
net current asset value	-762115000	-228665000	-233.29
invested capital	6947292000	7880501000	-11.84
average receivables	None	None	NaN
average payables	None	None	NaN
average inventory	None	None	NaN
days sales outstanding	68.42	46.07	48.50
days payables outstanding	57.69	63.54	-9.20
days of inventory on hand	47.4	66.32	-28.53
receivables turnover	1.32	1.95	-32.66
payables turnover	1.56	1.42	10.13
inventory turnover	1.9	1.36	39.91
roe	0.1	0.06	76.61
capex per share	0.05	0.07	-26.11

• ROE:

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 2.62 on 2024-06-30 Q2 from 4.12 on 2023-12-31 Q4, representing a change of -36.42%. Indicating a decrease in the relative valuation of the company's stock.

• Positive

  Current Ratio: Current Ratio increased to 1.29 on 2024-06-30 Q2 from 1.22 on 2023-12-31 Q4, representing a change of 5.21%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

• Neutral

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.29 on 2024-06-30 Q2 from 0.22 on 2023-12-31 Q4, representing a change of 28.66%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Positive Sentiment: Discounted Cash Flow value is 11.83 which is higher than current price 4.36, indicates the company may be undervalued.